Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report)’s stock price dropped 17.7% on Monday . The stock traded as low as $3.25 and last traded at $3.25. Approximately 312 shares traded hands during trading, a decline of 99% from the average session volume of 29,548 shares. The stock had previously closed at $3.95.
Analysts Set New Price Targets
Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, Raia Drogasil presently has a consensus rating of “Hold”.
Read Our Latest Stock Report on Raia Drogasil
Raia Drogasil Price Performance
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Recommended Stories
- Five stocks we like better than Raia Drogasil
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
